News 20.11.2020 Schlieren (Zurich), Switzerland, November 20, 2020 – Kuros Biosciences (SIX: KURN) today announced that it has won the 2020 Spine Technology Award, awarded by the widely-read industry publication Orthopedics This Week for outstanding innovations in the field, for its Fibrin-PTH (KUR-113) technology, which delivers targeted and controlled bone formation. The prestigious...
Events, External events
Event date: 19.11.2020
November 19th, 2020
8.30am-9.30am PDT
17.30pm-18.30pm CET
Go Global in Life Science Series in collaboration with Wilson Sonsini and Niederer Kraft Frey.
We would like to invite you to join us and our panel of experts to discuss best practices for venturing into the US market.
If you are a company in the life sciences...
Events, External events
Event date: 09.12.2020
Date: 9th December 2020
Time: 16.00 CET
Duration: 1 hour
What Does it Cover?
Imaging of live cells and tissues is a rapidly growing field and has revolutionized how biologists study cells, proteins and a multitude of processes and molecular interactions. Live cell imaging techniques allow scientists to observe cell structures, study dynamic processes...
News 06.11.2020 Schlieren, Switzerland – November 6, 2020 – Memo Therapeutics AG, an innovator in the field of antibody discovery and immune repertoire analysis, announced today that the company has raised CHF 14 million in Series B financing. The round was led by Swisscanto Invest by Zürcher Kantonalbank and included BERNINA BioInvest,...
News 29.10.2020 Zurich-Schlieren, Switzerland, October 29, 2020. Molecular Partners AG (SIX: MOLN), a clinical-stage biotech company that is developing a new class of custom-built protein drugs known as DARPin® therapeutics, announced today its interim management statement for the period ending September30, 2020. “Responding to the global COVID-19 pandemic requires an unprecedented effort on...